PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 1177.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-68.95%
Negative OCF growth while 1177.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-292.64%
Negative FCF growth while 1177.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-100.00%
Negative 10Y revenue/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Negative 3Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-100.00%
Negative 10Y net income/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-100.00%
Negative 5Y net income/share CAGR while 1177.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-100.00%
Negative 3Y CAGR while 1177.HK is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 1177.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
-97.76%
Inventory is declining while 1177.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
100.00%
BV/share growth of 100.00% while 1177.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.